These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18804834)

  • 1. Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines.
    Chen Z; Aspelund A; Kemble G; Jin H
    Virology; 2008 Oct; 380(2):354-62. PubMed ID: 18804834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist).
    Chen Z; Aspelund A; Kemble G; Jin H
    Virology; 2006 Feb; 345(2):416-23. PubMed ID: 16289204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cold adapted and temperature sensitive influenza A/Ann Arbor/6/60 virus, the master donor virus for live attenuated influenza vaccines, has multiple defects in replication at the restrictive temperature.
    Chan W; Zhou H; Kemble G; Jin H
    Virology; 2008 Oct; 380(2):304-11. PubMed ID: 18768193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.
    Hoffmann E; Mahmood K; Chen Z; Yang CF; Spaete J; Greenberg HB; Herlocher ML; Jin H; Kemble G
    J Virol; 2005 Sep; 79(17):11014-21. PubMed ID: 16103152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Drieszen-van der Cruijsen SK; Basten SM; Heldens JG; van den Bosch H; Rudenko LG
    J Gen Virol; 2010 Apr; 91(Pt 4):931-7. PubMed ID: 20007357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.
    Jin H; Lu B; Zhou H; Ma C; Zhao J; Yang CF; Kemble G; Greenberg H
    Virology; 2003 Feb; 306(1):18-24. PubMed ID: 12620793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).
    Isakova-Sivak I; Chen LM; Matsuoka Y; Voeten JT; Kiseleva I; Heldens JG; den Bosch Hv; Klimov A; Rudenko L; Cox NJ; Donis RO
    Virology; 2011 Apr; 412(2):297-305. PubMed ID: 21315402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).
    Cox NJ; Kitame F; Kendal AP; Maassab HF; Naeve C
    Virology; 1988 Dec; 167(2):554-67. PubMed ID: 2974219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.
    Buonagurio DA; Bechert TM; Yang CF; Shutyak L; D'Arco GA; Kazachkov Y; Wang HP; Rojas EA; O'Neill RE; Spaete RR; Coelingh KL; Zamb TJ; Sidhu MS; Udem SA
    Vaccine; 2006 Mar; 24(12):2151-60. PubMed ID: 16413951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a cold-adapted attenuated live H3N2 subtype influenza virus vaccine candidate.
    An WQ; Yang PH; Duan YQ; Luo DY; Tang C; Jia WH; Xing L; Shi XF; Zhang YJ; Liu XF; Wang XL
    Chin Med J (Engl); 2009 Dec; 122(23):2880-5. PubMed ID: 20092795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of a live attenuated influenza B virus vaccine candidate.
    Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL
    Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo.
    Crescenzo-Chaigne B; Naffakh N; van der Werf S
    Virology; 1999 Dec; 265(2):342-53. PubMed ID: 10600605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering of live attenuated influenza viruses.
    Jin H; Chen Z; Liu J; Kemble G
    Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.
    White CL; Chiem K; Perez DR; Santos J; Cardenas Garcia S; Nogales A; Martínez-Sobrido L
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34208979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
    Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
    Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping and screening of reassortant live-attenuated influenza B vaccine strain.
    Lee EY; Lee KH; Jung EJ; Jang YH; Seo SU; Kim HA; Seong BL
    J Virol Methods; 2010 May; 165(2):133-8. PubMed ID: 19883691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: independent segregation of temperature-sensitivity of virus replication from temperature-sensitivity of virion transcriptase activity during recombination of mutant A/Ann Arbor/6/60 with wild-type H3N2 strains.
    Kendal AP; Cox NJ; Galphin JC; Maassab HF
    J Gen Virol; 1979 Aug; 44(2):443-56. PubMed ID: 521798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation and phenotypic stability of influenza B/Texas/1/84 cold-adapted reassortant virus: studies in hamsters and chimpanzees.
    Snyder MH; London WT; Maassab HF; Murphy BR
    J Infect Dis; 1989 Oct; 160(4):604-10. PubMed ID: 2794557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.